Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05735184
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-02-09
Brief Title:
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With VenetoclaxAzacitidine Venetoclax or 73 in Patients With AML
Sponsor:
Kura Oncology Inc
Organization:
Kura Oncology Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia |
| Mixed Lineage Acute Leukemia |
| Mixed Lineage Leukemia Gene Mutation |
| Mixed Phenotype Acute Leukemia |
| Refractory AML |
| AML With Mutated NPM1 |
| Acute Myeloid Leukemia Recurrent |
| Acute Myeloid Leukemia in Relapse |
| NPM1 Mutation |
| KMT2Ar |
| Myeloid Sarcoma |
Keywords: